Quick Answer
Emergent BioSolutions Inc. reported Stockholders Equity of $482.80 million for fiscal year 2024.
Emergent BioSolutions Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $482.80M | -25.6% |
| 2023 | $649.30M | -53.2% |
| 2022 | $1.39B | -13.9% |
| 2021 | $1.61B | +11.1% |
| 2020 | $1.45B | +33.3% |
| 2019 | $1.09B | +7.7% |
| 2018 | $1.01B | +10.8% |
| 2017 | $912.30M | +53.0% |
| 2016 | $596.20M | -9.7% |
| 2015 | $660.00M | +19.3% |
| 2014 | $553.20M | +13.0% |
| 2013 | $489.62M | +10.9% |
| 2012 | $441.36M | +6.5% |
| 2011 | $414.25M | +12.1% |
| 2010 | $369.46M | +51.5% |
| 2009 | $243.81M | +22.3% |
| 2008 | $199.35M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $582.50M | +14.6% | +8.6% |
| June 30, 2025 | $536.20M | +38.8% | -3.0% |
| March 31, 2025 | $552.70M | -16.7% | +14.5% |
| December 31, 2024 | $482.80M | -25.6% | -5.0% |
| September 30, 2024 | $508.40M | -27.1% | +31.6% |
| June 30, 2024 | $386.30M | -59.7% | -41.8% |
| March 31, 2024 | $663.90M | -44.9% | +2.2% |
| December 31, 2023 | $649.30M | -53.2% | -6.9% |
- Emergent BioSolutions Inc. showed a decrease of -25.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2024 period, Emergent BioSolutions Inc.’s stockholders equity has grown by 142.2% (from $199.35 million to $482.80 million).
- The most recent figure is from Emergent BioSolutions Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 4, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: